Oruka Therapeutics (ORKA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Oruka Therapeutics (ORKA) is Neutral.

The composite score behind that read is -0.13, weighing +0.53 of bullish evidence against -0.30 bearish.

Oruka Therapeutics last closed at $84.38, -0.17% on the session.

Against the IVW growth benchmark the position is -1.09% over the forecast window.

The read is built from 12 underlying insights — 3 bullish and 9 bearish.

Agreement across those insights is 75%.

Oruka Therapeutics has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Oruka Therapeutics in the 27th percentile on return on equity, where 100 is best.

Oruka Therapeutics is classified under Health Care / Biotechnology, with a market capitalisation of $5.60B.

StockMap tracks Oruka Therapeutics as the 47th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Oruka Therapeutics ranks 95th of 344 in the group, against a group median of -0.21.